跳至主要内容
临床试验/NCT02529969
NCT02529969Unknown2 期

Curcumin Supplementation and Type 2 Diabetes

National Nutrition and Food Technology Institute2 个研究点 分布在 2 个国家目标入组 50 人开始时间: 2015年7月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
入组人数
50
试验地点
2
主要终点
Triglyceride

研究概览

简要总结

Diabetes mellitus is the most common endocrine disorder, causes many complications such as micro- and macro-vascular diseases. Various kinds of antidiabetic drugs have been developed, but most of them have side effects. Recently, the use of natural plant products has gained more attention among scientists in order to prevent diabetic vascular complications. Curcumin is a natural yellow product derived from the turmeric rhizome which has shown to be non-toxic and exhibits various bio¬logical activities such as anti-oxidant, anti-inflammatory, anti-carcinogenic, and anti-diabetic effects. Curcumin is effective in reducing glycemic index and hyperlipidemia in rodent models and is relatively inexpensive and safe. Most of the studies conducted on animal model, and just a few of them are on human model. The present study was planned to evaluate the effects of curcumin supplementation on serum levels of lipid profile and inflammatory markers in patients with type 2 diabetes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Tendency to participate
  • Age range of 40-65
  • Suffering from diabetes type 2 ( between 1 to 10 yeares)
  • BMI 18/5-30
  • Patients with diabetes who administer oral hypoglycemic agents and do not use

排除标准

  • patients with liver diseases
  • patients with kidney diseases
  • patients with inflammatory diseases
  • patients with liver diseases
  • Administering herbal agents
  • Administering multivitamins and minerals in past 3 months

研究组 & 干预措施

intervention

Active Comparator

500 mg curcumin capsule

干预措施: curcumin (Dietary Supplement)

placebo

Placebo Comparator

500 mg placebo

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Triglyceride

时间窗: 12 weeks

次要结局

  • C-Reactive Protein(12 weeks)

研究者

发起方
National Nutrition and Food Technology Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Azita Hekmatdoost

Principal Investigator

National Nutrition and Food Technology Institute

研究点 (2)

Loading locations...

相似试验

Effects of Curcumin Supplementation on Lipid Profile... | 临床试验